Advances in Targeted Therapies for Endometrial Cancer
Received Date: Feb 01, 2025 / Published Date: Feb 28, 2025
Abstract
Endometrial cancer remains a significant cause of morbidity among women worldwide, with advanced-stage disease posing therapeutic challenges. This article explores recent advances in targeted therapies, focusing on molecular pathways such as PI3K/AKT/mTOR and immune checkpoint inhibitors. We review clinical trial data, discuss treatment efficacy, and highlight future directions. Results indicate improved progression-free survival with targeted agents, though challenges like resistance persist. This comprehensive analysis underscores the potential of personalized medicine in improving outcomes for endometrial cancer patients.
Citation: Sarah JT (2025) Advances in Targeted Therapies for EndometrialCancer. Current Trends Gynecol Oncol, 10: 255.
Copyright: 漏 2025 Sarah JT. This is an open-access article distributed under theterms of the Creative Commons Attribution License, which permits unrestricteduse, distribution, and reproduction in any medium, provided the original author andsource are credited.
Select your language of interest to view the total content in your interested language
Share This Article
Recommended Journals
天美传媒 Access Journals
Article Usage
- Total views: 363
- [From(publication date): 0-0 - Dec 13, 2025]
- Breakdown by view type
- HTML page views: 278
- PDF downloads: 85
